Tianjin ZhongXin Pharmaceutical Group Corporation Limited is the first company in China that has listed both S-shares in Singapore and A shares in China. Owning 52 branch companies and subsidiaries with holding and minor stakes, it is a comprehensively and vertically integrated pharmaceutical group with investment and holding functions. The business of ZhongXin covers a wide range of fields including botanical extracts, traditional chinese medicine, bioengineering drugs, chemical raw materials, ...